Works matching IS 00099236 AND DT 2016 AND VI 99 AND IP 6
Results: 16
Pharmacogenomic information in FDA-approved drug labels: Application to pediatric patients.
- Published in:
- Clinical Pharmacology & Therapeutics, 2016, v. 99, n. 6, p. 622, doi. 10.1002/cpt.330
- By:
- Publication type:
- Article
Educational innovations in clinical pharmacogenomics.
- Published in:
- Clinical Pharmacology & Therapeutics, 2016, v. 99, n. 6, p. 582, doi. 10.1002/cpt.352
- By:
- Publication type:
- Article
Patient-derived xenografts as tools in pharmaceutical development.
- Published in:
- Clinical Pharmacology & Therapeutics, 2016, v. 99, n. 6, p. 612, doi. 10.1002/cpt.354
- By:
- Publication type:
- Article
Issue Information - Subscription Page.
- Published in:
- Clinical Pharmacology & Therapeutics, 2016, v. 99, n. 6, p. 564, doi. 10.1002/cpt.230
- Publication type:
- Article
ASCPT News.
- Published in:
- Clinical Pharmacology & Therapeutics, 2016, v. 99, n. 6, p. 577, doi. 10.1002/cpt.370
- Publication type:
- Article
The Bugs Within Our Body: The Human Microbiota.
- Published in:
- Clinical Pharmacology & Therapeutics, 2016, v. 99, n. 6, p. 570, doi. 10.1002/cpt.371
- By:
- Publication type:
- Article
Intestinal Microbiota in Inflammatory Bowel Disease and Carcinogenesis: Implication for Therapeutics.
- Published in:
- Clinical Pharmacology & Therapeutics, 2016, v. 99, n. 6, p. 585, doi. 10.1002/cpt.348
- By:
- Publication type:
- Article
Issue Information - Ed Board.
- Published in:
- Clinical Pharmacology & Therapeutics, 2016, v. 99, n. 6, p. 563, doi. 10.1002/cpt.228
- Publication type:
- Article
Issue Information - TOC.
- Published in:
- Clinical Pharmacology & Therapeutics, 2016, v. 99, n. 6, p. 565, doi. 10.1002/cpt.229
- Publication type:
- Article
Complexities of Gut Microbiome Dysbiosis in the Context of HIV Infection and Antiretroviral Therapy.
- Published in:
- Clinical Pharmacology & Therapeutics, 2016, v. 99, n. 6, p. 600, doi. 10.1002/cpt.363
- By:
- Publication type:
- Article
The complex interplay of diet, xenobiotics, and microbial metabolism in the gut: Implications for clinical outcomes.
- Published in:
- Clinical Pharmacology & Therapeutics, 2016, v. 99, n. 6, p. 588, doi. 10.1002/cpt.366
- By:
- Publication type:
- Article
In this Issue.
- Published in:
- Clinical Pharmacology & Therapeutics, 2016, v. 99, n. 6, p. 569, doi. 10.1002/cpt.368
- Publication type:
- Article
Highlights.
- Published in:
- Clinical Pharmacology & Therapeutics, 2016, v. 99, n. 6, p. 575, doi. 10.1002/cpt.369
- Publication type:
- Article
OCT1 mediates hepatic uptake of sumatriptan and loss-of-function OCT1 polymorphisms affect sumatriptan pharmacokinetics.
- Published in:
- Clinical Pharmacology & Therapeutics, 2016, v. 99, n. 6, p. 633, doi. 10.1002/cpt.317
- By:
- Publication type:
- Article
Single dose, CYP2D6 genotype-stratified pharmacokinetic study of atomoxetine in children with ADHD.
- Published in:
- Clinical Pharmacology & Therapeutics, 2016, v. 99, n. 6, p. 642, doi. 10.1002/cpt.319
- By:
- Publication type:
- Article
Inherited variation in OATP1B1 is associated with treatment outcome in acute myeloid leukemia.
- Published in:
- Clinical Pharmacology & Therapeutics, 2016, v. 99, n. 6, p. 651, doi. 10.1002/cpt.315
- By:
- Publication type:
- Article